Genome Editing by Guided Endonuclease and Single-stranded Oligonucleotide
AssigneeNovozymes A/S
InventorsNicholas Jochumsen, Gloria Muzzi-Erichsen
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovozymes A/S
InventorsNicholas Jochumsen, Gloria Muzzi-Erichsen
Estimating the term…
The present invention relates to methods for introducing one or more desired nucleotide modification(s) in a target sequence in the genome of a microorganism cell using a polynucleotide-guided endonuclease, e.g., the MAD7 enzyme isolated and described by Inscripta™ or the well-known Streptococcus pyogenes Cas9, together with a suitable guide RNA for each target sequence to be modified, to generate a site-specific cut or nick in at least one genome target sequence, followed by the repair of the cut(s) and/or nick(s) via at least one oligonucleotide capable of hybridizing with the at least one genome target sequence, thereby highly efficiently introducing the one or more desired modification(s) into the target sequence.
1-14. (canceled)
15:
16:
17:
18:
19:
20:
21:
22:
23:
24:
25:
26:
27:
28:
29:
30:
31:
32:
33:
34: